Wczytywanie kursów wyceny...
Prognoza
| Kupuj |
1 |
| Trzymaj |
0 |
| Sprzedaj |
0 |
Dyskusje w społeczności
Nie ma jeszcze dyskusji o tym aktywie.
Rozpocznij dyskusjęWiadomości Przejdź do aktualności
Fresenius SE: €100 investment three years ago would be worth +55.95%
If €100 had been invested in Fresenius SE three years ago, you would now hold 3.563 shares with a value of €155.95, equivalent to a performance of 55.95%. The price rose from €28.07 to €43.78 (as of 06.10.2026). Fresenius SE most recently reached a market capitalization of €24.71 billion. Stock splits and dividends are not included in the calculation. » Więcej na finanzen.net
Fresenius SE investment ten years ago would have resulted in about a 37% loss
Ten years ago the Fresenius SE share traded at €72.77; on 22 September 2026 the price was €45.57. An investment of €1,000 ten years ago would now be worth only about €626.22 (−37.38%), with stock splits and dividends not included in the calculation. Fresenius SE’s market capitalization was most recently around €25.40 billion. » Więcej na finanzen.net
Fresenius SE share: one-year loss of 3.69% on a €1,000 investment
A €1,000 investment in Fresenius SE one year ago (closing price €46.50) would have been worth only €963.12 on 01.09.2026 at a price of €44.79, corresponding to a loss of 3.69%. The most recently reported market value of Fresenius SE is €25.48 billion. The calculation does not take stock splits or dividend payments into account. » Więcej na finanzen.net
Fresenius SE: 10-year investment would mean around 30% loss
An investment of 100 EUR in Fresenius SE ten years ago would, according to calculations, be worth about 70.05 EUR today, a decline of 29.95%. Ten years ago the share closed at 65.45 EUR; the closing price on 25.08.2026 was 45.85 EUR. The market valuation most recently is 25.93 billion euros. The calculation does not take into account stock splits and dividends. » Więcej na finanzen.net
Historyczne dywidendy Dywidendy
Wszystkie wskaźniki dywidendowe Wszystkie wskaźnikiDane finansowe spółki
| (EUR) | wrzesień 2026 | YoY |
|---|---|---|
| Przychody | 5,88 mld | 7,27% |
| Zysk brutto | 1,53 mld | 17,92% |
| Zysk netto | 371 mln | 7,85% |
| EBITDA | 815 mln | 2,51% |
Dane fundamentalne
| Wskaźnik | Wartość |
|---|---|
Kapitalizacja rynkowa | 30,14 mld € |
Liczba akcji | 563,24 mln |
Maksimum/minimum z 52 tygodni | 54,35 € - 35,11 € |
Stopa dywidendy | 1,96% |
Dywidendy TTM | 1,05 € |
Beta | 0,77 |
C/Z (PE Ratio) | 19,11 |
PEG (PEG Ratio) | 0,51 |
C/WK (PB Ratio) | 1,47 |
C/S (PS Ratio) | 1,27 |
Profil spółki
| Nazwa | Fresenius |
| CEO | Michael Sen |
| Siedziba | Bad Homburg vor der Höhe,
he Niemcy |
| Strona internetowa | |
| Sektor | Ochrona zdrowia |
| Branża | Ochrona zdrowia: sprzęt i produkty |
| Pracownicy | 178 394 |